Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Arc Tx ARCT Stock Technical Momentum Smart Money Active 20260420 Gen GENVR Stock Why Margin Expansion 575 20260420 ANTX AN2 Thera reports wider than expected Q4 2025 EPS loss shares fall 208 percent on investor disappointment Invesco DB US Dollar Index Bullish Fund UUP Bullish Catalysts Emerge Post Recent Pullback Amid Geopolitical and Macro Volatility Crane Harbor CHAC Stock The Bear Case 848 20260420 VSH Vishay Intertechnology shares drop 3 as EPS misses by 50 despite revenue growth of 45 AMS AmSharedHosp posts steep Q4 2025 EPS miss against estimates shares rise 342 SMTI Sanara MedTech climbs 25 percent in daily trading despite Q4 2025 EPS landing below analyst estimates ARK Innovation ETF ARKK Portfolio Reallocation 72M AMD Divestment Increased Exposure to LargeCap AI Plays US Stocks Slide as Bond Yields Rise Tech Retreats on Inflation Concerns and Iran War Progress Dave Inc DAVE Q1 2026 Earnings Surprise EPS 402 Up Significant Is Lincoln LNC Still a Buy After 236 Rally 20260518 Solo Brands SBDS Stock Slides 565 Support at 445 20260514 Cass Info CASS Surges 103 Nearing 4892 Resistance 20260520 Is Modular Medical MODD Still a Buy After 1862 Rally 20260520 Green Plains GPRE Q1 2026 Earnings Why the Beat Matters Ingles IMKTA Stock Analysis 144 Loss Key Levels 20260520 OVLY Q3 2023 Earnings Steady Earnings Per Share of 089 Amidst Stable Bank Operations Kodiak AI Inc KDK Q1 2026 Earnings Stunning EPS Beat of 15045 but Stock Declines BNS Q1 2026 Earnings EPS Beat on 389 Surprise PMVP Q1 2026 Earnings Narrower Loss Slightly Beats Estimates as Development Advances ECO Q1 2026 Earnings EPS Beats Estimates by a Wide Margin Stock Dips Despite Strong Performance Definium Therapeutics DFTX Slides Slightly Approaches Key Support Level Kura Oncology Stock Slides Testing Key Support Levels Amid Biotech Sector Weakness XAI Madison Equity Premium Income Fund MCN Holds Near Support Amid Modest Decline Rand Capital RAND Sees a 15 Upswing as Shares Approach Key Resistance